共 756 条
[1]
Williams Hywel D.(2013)Strategies to Address Low Drug Solubility in Discovery and Development Pharmacol Rev 65 315-499
[2]
Trevaskis Natalie L.(2001)Amorphous pharmaceutical solids: preparation, characterization and stabilization Advanced Drug Delivery Reviews 48 27-42
[3]
Charman Susan A.(2004)Amorphous Drug Delivery Systems: Molecular Aspects, Design, and Performance Crit Rev Ther Drug Carrier Syst 21 133-193
[4]
Shanker Ravi M.(2009)Commentary: Towards Physico-Relevant Dissolution Testing: The Importance of Solid-State Analysis in Dissolution Dissolution Technol. 16 47-54
[5]
Charman William N.(2014)Refining stability and dissolution rate of amorphous drug formulations Expert Opinion on Drug Delivery 11 977-989
[6]
Pouton Colin W.(2011)Selection of oral bioavailability enhancing formulations during drug discovery Drug Development and Industrial Pharmacy 38 235-247
[7]
Porter Christopher J. H.(2010)Drug–Polymer Solubility and Miscibility: Stability Consideration and Practical Challenges in Amorphous Solid Dispersion Development Journal of Pharmaceutical Sciences 99 2941-2947
[8]
Yu Lian(2019)Advances in coamorphous drug delivery systems Acta Pharmaceutica Sinica B 9 19-35
[9]
Kaushal Aditya Mohan(2016)Recent advances in co-amorphous drug formulations Advanced Drug Delivery Reviews 100 116-125
[10]
Gupta Piyush(2021)Considerations for the selection of co-formers in the preparation of co-amorphous formulations International Journal of Pharmaceutics 602 120649-76